NO20061138L - Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi - Google Patents

Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Info

Publication number
NO20061138L
NO20061138L NO20061138A NO20061138A NO20061138L NO 20061138 L NO20061138 L NO 20061138L NO 20061138 A NO20061138 A NO 20061138A NO 20061138 A NO20061138 A NO 20061138A NO 20061138 L NO20061138 L NO 20061138L
Authority
NO
Norway
Prior art keywords
glycemia
hyperglycemia
prevention
treatment
stabilize
Prior art date
Application number
NO20061138A
Other languages
English (en)
Norwegian (no)
Inventor
Lucien Lesaffre
Original Assignee
Lesaffre & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesaffre & Cie filed Critical Lesaffre & Cie
Publication of NO20061138L publication Critical patent/NO20061138L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20061138A 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi NO20061138L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018222 2003-08-11
EP03020253 2003-09-08
PCT/EP2004/008933 WO2005021015A1 (fr) 2003-08-11 2004-08-10 Ecorces de levures pour le traitement ou la prevention de l’hyperglycemie ou pour la stabilisation de la glycemie

Publications (1)

Publication Number Publication Date
NO20061138L true NO20061138L (no) 2006-05-10

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061138A NO20061138L (no) 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Country Status (17)

Country Link
US (2) US7459159B2 (https=)
EP (1) EP1663266B1 (https=)
JP (2) JP4808619B2 (https=)
KR (1) KR101076209B1 (https=)
AU (1) AU2004267928B2 (https=)
BR (1) BRPI0413481A (https=)
CA (1) CA2534791C (https=)
DK (1) DK1663266T3 (https=)
EA (1) EA009677B1 (https=)
ES (1) ES2405934T3 (https=)
MA (1) MA28072A1 (https=)
MX (1) MXPA06001741A (https=)
NO (1) NO20061138L (https=)
NZ (1) NZ545594A (https=)
PL (1) PL1663266T3 (https=)
PT (1) PT1663266E (https=)
WO (1) WO2005021015A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
EP2062588A4 (en) * 2006-08-24 2011-06-08 Kirin Holdings Kk COMPOSITION FOR TREATING A SKIN CONDITION
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン１２産生抑制剤
FR2919187B1 (fr) 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) * 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ro) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Tulpină de drojdii Saccharomyces cerevisiae - producătoare de manani
WO2017179691A1 (ja) * 2016-04-14 2017-10-19 テーブルマーク株式会社 血糖値低下用又はｇｉ値低減用の食品組成物又は組み合わせ
US20190307823A1 (en) * 2016-05-17 2019-10-10 KOHJIN Life Sciences Co., Ltd. Yeast extract having diabetes prevention effect
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
PL3685681T3 (pl) 2019-01-23 2024-10-21 Lesaffre Et Compagnie Produkt drożdżowy i zawierająca go kompozycja do zastosowania jako środek prebiotyczny

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
KR19980703564A (ko) * 1993-12-28 1998-11-05 빌르에르 고 가용성 섬유의 시리얼 식품
DE4413023A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
CA2266929A1 (en) * 1996-09-25 1998-04-02 Graceline Limited Beta-glucan products and extraction processes from cereals
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
FR2800076B1 (fr) * 1999-10-22 2003-11-14 Lesaffre & Cie Mannoproteines solubles
US20040023923A1 (en) * 2000-07-03 2004-02-05 Morgan Keith Raymond Cold water soluble beta-glucan product and process for preparing the same
CN100391439C (zh) * 2001-04-27 2008-06-04 味之素株式会社 免疫增强剂
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Also Published As

Publication number Publication date
AU2004267928A1 (en) 2005-03-10
MA28072A1 (fr) 2006-08-01
US20090022758A1 (en) 2009-01-22
BRPI0413481A (pt) 2006-10-17
US20060257422A1 (en) 2006-11-16
EP1663266B1 (fr) 2013-02-20
KR101076209B1 (ko) 2011-10-24
CA2534791C (fr) 2014-10-28
ES2405934T3 (es) 2013-06-04
PL1663266T3 (pl) 2013-07-31
NZ545594A (en) 2009-09-25
DK1663266T3 (da) 2013-05-13
JP4808619B2 (ja) 2011-11-02
JP2007501829A (ja) 2007-02-01
WO2005021015A1 (fr) 2005-03-10
CA2534791A1 (fr) 2005-03-10
US7459159B2 (en) 2008-12-02
EA200600402A1 (ru) 2006-08-25
JP2011178794A (ja) 2011-09-15
KR20060037432A (ko) 2006-05-03
PT1663266E (pt) 2013-04-30
AU2004267928B2 (en) 2010-10-21
MXPA06001741A (es) 2006-05-12
EA009677B1 (ru) 2008-02-28
EP1663266A1 (fr) 2006-06-07

Similar Documents

Publication Publication Date Title
NO20055832L (no) Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
MX345056B (es) Diagnóstico y tratamiento de deficiencia de sulfatasa múltiple y otras deficiencias de sulfatasa.
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
NO20061138L (no) Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi
WO2003101397A3 (en) Tetravalent dengue vaccines
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
DE60330485D1 (de) Zur behandlung von diabetes
ATE485366T1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
DK1768490T3 (da) Systemer og fremgangsmåder til ex-vivo-organpleje
ATE447574T1 (de) 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
EA200870019A1 (ru) Лактамовые соединения и способы их применения
ATE354563T1 (de) Sulfonderivate zur hemmung von gamma-secretase
DE60329533D1 (de) Cyclische sulfamide zur inhibierung von gamma-sekretase
ATE458731T1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
MX2007005590A (es) Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas.
NO20075815L (no) Formuleringer og metoder for behandling av amyloidose
NO20050717L (no) Metode og sammensetninger for modulering av T hjelpe (TH) celleutvikling og funksjon
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
WO2003103571A3 (en) Flavivirus vaccines
NO20061911L (no) Immunogene sammensetninger
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
UA83057C2 (ru) Замещенные производные диоксида тиазолбензоизотиазола и их применение

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application